2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Amina Sakly ◽  
Bart De Wever ◽  
Balraj Jutla ◽  
Milan Satia ◽  
Jean Pierre Bogaert

2020 ◽  
Vol 13 (3) ◽  
pp. 253-260
Author(s):  
K. Anand Babu ◽  
R. Ram Narayanan

Recurrent Aphthous Stomatitis (RAS) is one of the most common pathological conditions with ulcers in the oral mucosa. Various conventional medicines are available in the market for RAS but due to a range of factors people are getting affected by RAS gradually. More over conventional medicines are all having the side effects so the alternative system for the treatment of RAS came in to the market. Although herbal medicines are widely used in India and other countries and multiple studies are conducted in this regard, but still many of the herbal plants are not utilized though they are having traditional claim. Aim of this is review is suggesting the herbal plants which are claimed for the treatment of mouth ulcer but scientifically validated for gastric ulcer by using animal models should also be validated for mouth ulcer by clinical trials and also which are used traditionally but not yet concentrated can be evaluated and used for the treatment of RAS.


2017 ◽  
Vol 3 (2) ◽  
pp. 69
Author(s):  
Rahmi Amtha ◽  
M Marcia ◽  
Anggia Irma Aninda

Mouth ulcer plaster is effective in accelerating the healing of recurrent aphthous stomatitis and traumatic ulcers. Recurrent aphthous stomatitis (RAS) is one of the most commonly occurring oral diseases. The prevalence of oral ulceration worldwide is 4%, with RAS having the largest proportion (25%). Recurrent aphthous stomatitis is oral ulceration which has a self-limiting disease, but the specific medication to reduce pain caused by lesion is still less varied nowadays. This study aimed to examine the differences in the effectiveness between topical application of hyaluronic acid (HA), mouth ulcer plaster (MUP) and 0.1% triamcinolone acetonide (TA) as a positive control in the healing of RAS and traumatic ulcers (TU). This was a quasi-experimental study by measuring the lesion diameter as well as visual analogue scale (VAS) pre- and post-administration of three types of medication. Kruskal-walis test results show that there are differences in effectiveness (p=0.000) of the three types of medication to cure RAS and TU. There are signicant differences in the reduction of RAS and TU lesion diameter (p = 0.015) and VAS (p = 0.038) with the use of HA and MUP on the 4th day. There is no signicant difference in effectiveness (diameter and VAS) of MUP and TA medication on the fourth day (p = 0.880 and p = 1.000 respectively). There is no signicant difference among HA, MUP and TA on the healing of the lesions on the seventh day (p>0.05). It can be concluded that the effectiveness of MUP is similar to that of topical medications containing corticosteroids in the healing of RAS and traumatic ulcers.ABSTRAKStomatitis aftosa rekuren (SAR) merupakan salah satu penyakit mulut yang paling umum terjadi. Prevalensi ulserasi mulut di seluruh dunia adalah 4%, dengan SAR menempati urutan terbesar yaitu 25%. Stomatitis aftosa rekuren merupakan ulserasi mulut yang memiliki self-limiting disease, namun sediaan obat yang spesifik untuk mengurangi rasa sakit yang ditimbulkan lesi sampai saat ini masih kurang bervariasi. Penelitian ini bertujuan untuk mengetahui perbedaan efektivitas antara aplikasi topikal asam hialuronat (AH), plester sariawan (PS) serta triamcinolone acetonide 0,1% (TA) sebagai kontrol positif dalam menyembuhkan SAR dan ulkus traumatikus (UT). Jenis penelitian eksperimental klinis kuasi dengan mengukur diameter lesi serta skala visual analog (VAS) pra dan paska pemberian tiga jenis obat. Hasil uji Kruskal-walis menunjukkan bahwa terdapat perbedaan efektivitas (p=0,000) ketiga jenis obat terhadap penyembuhan SA dan UT. Terdapat perbedaan bermakna penurunan diameter lesi (p = 0,015) dan VAS (p = 0,038) SAR dan UT dengan penggunaan AH dan PS pada hari ke-4. Tidak ada perbedaan bermakna efektivitas (diameter dan VAS) obat PS dan TA pada hari ke-4 (p = 0,880 dan p = 1,000 secara berurutan). Tidak ada perbedaan bermakna antara masing-masing obat AH, PS dan TA terhadap penyembuhan lesi pada hari ke-7 (p >0,05). Kesimpulan efektivitas PS sama dengan obat topikal yang mengandung kortikosteroid dalam menyembuhkan stomatitis aftosa dan ulkus traumatikus.


2021 ◽  
Vol 6 (1) ◽  
pp. 1318-1323
Author(s):  
Taufik Septiyan ◽  
Gofarana Wilar ◽  
Nasrul Wathoni

A mouth ulcer or recurrent aphthous stomatitis (RAS) is a mouth mucous tissue inflammation. This disease mainly occurs in patients 10-40 years of age, preferably in women and high socioeconomic backgrounds. The cause of mouth ulcers or RAS could be trauma, infection, digestive problems, or blood disorders. Herbal practitioners widely use herbs, folks, and society to treat various diseases. This research aimed to describe the herbal treatment for RAS. The review results show there are nine plants with the ability to cure RAS, they are Persea americana Mill., Averrhoa bilimbi L., Abrus precatorius Linn., Camellia sinensis (L.) Kuntze., Psidium guajava L., Kaempferia galanga Linn., Aloe vera, Curcuma longa and Citrus hystrix DC. The most parameters used in the studies are clinical trials and in vitro tests.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Martina Girardelli ◽  
Erica Valencic ◽  
Valentina Moressa ◽  
Roberta Margagliotta ◽  
Alessandra Tesser ◽  
...  

Abstract Background Recurrent aphthous stomatitis with systemic signs of inflammation can be encountered in inflammatory bowel disease, Behçet’s disease (BD), Systemic Lupus Erythematosus (SLE). In addition, it has been proposed that cases with very early onset in childhood can be underpinned by rare monogenic defects of immunity, which may require targeted treatments. Thus, subjects with early onset recurrent aphthous stomatitis receiving a clinical diagnosis of BD-like or SLE-like disease may deserve a further diagnostic workout, including immunologic and genetic investigations. Objective To investigate how an immunologic, genetic and transcriptomics assessment of interferon inflammation may improve diagnosis and care in children with recurrent aphthous stomatitis with systemic inflammation. Methods Subjects referred to the pediatric rheumatologist for recurrent aphthous stomatitis associated with signs of systemic inflammation from January 2015 to January 2020 were enrolled in the study and underwent analysis of peripheral lymphocyte subsets, sequencing of a 17-genes panel and measure of interferon score. Results We enrolled 15 subjects (12 females, median age at disease onset 4 years). The clinical diagnosis was BD in 8, incomplete BD in 5, BD/SLE overlap in 1, SLE in 1. Pathogenic genetic variants were detected in 3 patients, respectively 2 STAT1 gain of function variants in two patients classified as BD/SLE overlap and SLE, and 1 TNFAIP3 mutation (A20 haploinsufficiency) in patients with BD. Moreover 2 likely pathogenic variants were identified in DNASE1L3 and PTPN22, both in patients with incomplete BD. Interferon score was high in the two patients with STAT1 GOF mutations, in the patient with TNFAIP3 mutation, and in 3 genetic-negative subjects. In two patients, the treatment was modified based on genetic results. Conclusions Although recurrent aphthous stomatitis associated with systemic inflammation may lead to a clinical diagnosis of BD or SLE, subjects with early disease onset in childhood deserve genetic investigation for rare monogenic disorders. A wider genetic panel may help disclosing the genetic background in the subset of children with increased interferon score, who tested negative in this study.


2004 ◽  
Vol 131 (2) ◽  
pp. P242-P242
Author(s):  
Israel Brama ◽  
Boaz Mizrachi

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 223.3-223
Author(s):  
E. Lovšin ◽  
J. Kovac ◽  
T. Tesovnik ◽  
N. Toplak ◽  
D. Perko ◽  
...  

Background:Periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome is the most common autoinflammatory disease in children, often grouped together with hereditary periodic fever syndromes, although its cause and hereditary nature remain unexplained.Objectives:We investigated whether a differential DNA methylation was present in DNA from peripheral blood mononuclear cells (PBMC) in patients with PFAPA versus a group of healthy young individuals.Methods:A whole epigenome analysis (MeDIP and MBD) was performed using pooled DNA libraries enriched for methylated genomic regions. Of identified candidate genes, two with most significantly different methylation leves were further evaluated with methylation specific restriction enzymes coupled with qPCR (MSRE-qPCR).Results:The analysis showed thatPIK3AP1andSPON2intronic gene regions are differentially methylated in patients with PFAPA. MSRE-qPCR proved as a quick, reliable and cost-effective method to confirm results from MeDIP and MBD.Conclusion:Our findings indicate that B cell adapter protein (BCAP) as PI3K binding inhibitor of inflammation and spondin-2 (SPON2) as a pattern recognition molecule and integrin ligand could play a role in etiology of PFAPA. Their role and impact of changed DNA methylation in PFAPA etiology and autoinflammation need further investigation.References:[1]Wekell P. Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome – PFAPA syndrome. Press Medicale [Internet]. 2019;48(1):e77–87. Available from:https://doi.org/10.1016/j.lpm.2018.08.016[2]K. Theodoropoulou, F. Vanoni, and M. Hofer, “Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome: a Review of the Pathogenesis,”Curr. Rheumatol. Rep., vol. 18:18, 2016.[3]Carpentier SJ, Ni M, Duggan JM, James RG, Cookson BT, Hamerman JA. The signaling adaptor BCAP inhibits NLRP3 and NLRC4 inflammasome activation in macrophages through interactions with Flightless-1. Sci Signal. 2019;12(581).[4]He YW, Li H, Zhang J, Hsu CL, Lin E, Zhang N, et al. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat Immunol. 2004;5(1):88–97.Disclosure of Interests:None declared


Sign in / Sign up

Export Citation Format

Share Document